Allison Morningstar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Allison Morningstar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andrew H. Chang
Gladstone Institutes
1 shared publication - Bryan Higashikubo
Gladstone Institutes
1 shared publication - Eleonora Aronica
Department of (Neuro)pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
1 shared publication - Frances S Cho
UCSF/Gladstone Institutes
1 shared publication - Jeanne Saraiva da Paz
Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, USA
1 shared publication - Logan J Kuhn
Annexon Biosciences
1 shared publication
Latest Publications
- Open Access
Complement factor C1q mediates chronic neuron loss and inflammation post-brain injury
While traumatic brain injury (TBI) acutely disrupts the cortex, most TBI-related disabilities reflect secondary injuries that accrue over time. The thalamus is a likely site of secondary damage because of its reciprocal connections with the cortex. Using a mouse model of cortical injury that does not directly damage subcortical structures, we found a chronic increase in C1q expression specifically in the corticothalamic circuit. Increased C1q expression co-localized with neuron loss and chronic inflammation, and correlated with altered cortical rhythms. Blocking C1q counteracted most of these outcomes, suggesting that C1q is a disease modifier in TBI. Since the corticothalamic circuit is important for sensory processing, attention, cognition, and sleep, all of which can be impaired by TBI, this circuit could be a new target for treating TBI-related disabilities.
Open AccessComplement factor C1q mediates chronic neuron loss and inflammation post-brain injury
While traumatic brain injury (TBI) acutely disrupts the cortex, most TBI-related disabilities reflect secondary injuries that accrue over time. The thalamus is a likely site of secondary damage because of its reciprocal connections with the cortex. Using a mouse model of cortical injury that does not directly damage subcortical structures, we found a chronic increase in C1q expression specifically in the corticothalamic circuit. Increased C1q expression co-localized with neuron loss and chronic inflammation, and correlated with altered cortical rhythms. Blocking C1q counteracted most of these outcomes, suggesting that C1q is a disease modifier in TBI. Since the corticothalamic circuit is important for sensory processing, attention, cognition, and sleep, all of which can be impaired by TBI, this circuit could be a new target for treating TBI-related disabilities.